American Heart Journal
Volume 148, Issue 5 , Pages 783-788 , November 2004

Detection of increased temperature of the culprit lesion after recent myocardial infarction: The favorable effect of statins

  • Konstantinos Toutouzas, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
    • Corresponding Author InformationReprint requests: Dr. Konstantinos Toutouzas, Hippokration Hospital, Cardiology, 24 Karaoli and Dimitriou str, Holargos, Athens 15562, Greece
  • ,
  • Sophia Vaina, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • Eleftherios Tsiamis, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • Manolis Vavuranakis, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • John Mitropoulos, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • Eirini Bosinakou, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • Pavlos Toutouzas, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece
  • ,
  • Christodoulos Stefanadis, MD

      Affiliations

    • Department of Cardiology, Athens Medical School, Athens, Greece

Received 10 September 2003 ,Accepted 2 May 2004.

References 

  1. Jonasson L, Holm J, Skalli O, et al.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arterioscler Thromb. 1986;6:131–138
  2. van der Wal AC, Becker AE, van der Loos CM, et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44
  3. van der Wal AC, Piek JJ, de Boer OJ, et al.  Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 1998;80:14–18
  4. Moreno PR, Falk E, Palacios IF, et al.  Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 1994;90:775–778
  5. Spagnoli LG, Bonanno E, Mauriello A, et al.  Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2002;40:1579–1588
  6. Naruko T, Ueda M, Haze K, et al.  Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894–2900
  7. Buffon A, Biasucci LM, Liuzzo G, et al.  Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5–12
  8. Kyne L, Hausdorff JM, Knight E, et al.  Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J. 2000;139:94–100
  9. Zebrack JS, Anderson AJ. The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep. 2002;4:278–288
  10. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al.  Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques (potential implications for inflammation and plaque instability). Circulation. 2000;101:1372–1378
  11. Blankenberg S, Rupprecht HJ, Bickel C, et al.  Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336–1342
  12. Blankenberg S, Tiret L, Bickel C, et al.  Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24–30
  13. Atalar E, Aytemir K, Haznedaroglu I, et al.  Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol. 2001;78:69–73
  14. Cusack MR, Marber MS, Lambiase PD, et al.  Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 2002;39:1917–1923
  15. Casscells W, Hathorn B, David M, et al.  Thermal detection of cellular infiltrates in living atherosclerotic plaques (possible implications for plaque rupture and thrombosis). Lancet. 1996;347:1447–1451
  16. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al.  Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo (a new method of detection by application of a special thermography catheter). Circulation. 1999;99:1965–1971
  17. Stefanadis C, Diamantopoulos L, Dernellis J, et al.  Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol. 2000;32:43–52
  18. Stefanadis C, Toutouzas K, Vavuranakis M, et al.  Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J. 2002;23:1664–1669
  19. Verheye S, De Meyer GR, Van Langenhove G, et al.  In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation. 2002;105:1596–1601
  20. Stefanadis C, Toutouzas P. In vivo local thermography of coronary artery atherosclerotic plaques in humans. Ann Intern Med. 1998;129:1079–1080
  21. DiSciascio G, Cowley MJ, Goudreau E, et al.  Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy (in vivo evidence of thrombosis, ulceration, and inflammation). Am Heart J. 1994;128:419–426
  22. Zeiher AM, Goebel H, Schachinger V, et al.  Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 1995;9:941–947
  23. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084–1088
  24. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol. 1997;181:93–99
  25. Hajj-Ali R, Zareba W, Ezzeddine R, et al.  Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001;88:1221–1224
  26. Ault K, Cannon C, Mitchell J, et al.  Platelet activation in patients after an acute coronary syndrome (results from the TIMI-12 trial). J Am Coll Cardiol. 1999;33: 643–39
  27. Biasucci LM, Liuzzo G, Grillo RL, et al.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. J Am Coll Cardiol. 1999;99:855–860
  28. Speidl WS, Graf S, Hornykewycz S, et al.  High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J. 2002;144:449–455
  29. Ridker PM, Rifai N, Pfeffer M, et al.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149–2153
  30. Mulvihill NT, Foley JB, Murphy R, et al.  Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 2000;36:1210–1216
  31. Ito T, Ikeda U, Shimpo M, et al.  HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Cardiovasc Drugs Ther. 2002;16:121–126
  32. Bourcier T, Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:556–562
  33. Jialal I, Stein D, Balis D, et al.  Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 2001;103:1933–1935
  34. Cipollone F, Fazia M, Iezzi A, et al.  Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation. 2003;107:1479–1485
  35. Stefanadis C, Toutouzas K, Tsiamis E, et al.  Increased local temperature in human coronary atherosclerotic plaques (an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention). J Am Coll Cardiol. 2001;37:1277–1283
  36. Asakura M, Ueda Y, Yamaguchi O, et al.  Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction (an angioscopic study). J Am Coll Cardiol. 2001;37:1284–1288
  37. Stefanadis C, Toutouzas K, Tsiamis E, et al.  Thermal heterogeneity in stable human coronary atherosclerotic plaques is underestimated in vivo (the “cooling effect” of blood flow). J Am Coll Cardiol. 2003;41:403–408
  38. Stefanadis C, Toutouzas K, Vavuranakis M, et al.  New balloon-thermography catheter for in vivo temperature measurements in human coronary atherosclerotic plaques (A novel approach for thermography?). Catheter Cardiovasc Interv. 2003;58:344–350

PII: S0002-8703(04)00261-3

doi: 10.1016/j.ahj.2004.05.013

American Heart Journal
Volume 148, Issue 5 , Pages 783-788 , November 2004